spacer
The Healthcare Sales & Marketing Network celebrates 21 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  cord blood 

 HSMN NewsFeed - 8 Jan 2019
Cellenkos, Inc. Appoints Elizabeth Read as Chief Technology Officer, Adding Technology and Regulatory Affairs Expertise to its Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2018
Cellenkos, Inc. Announces Alick Sun as Senior Vice President for Corporate and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2018
Singlera Genomics Raises $60 Million in Series A+ Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 21 Aug 2017
Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS
Biopharmaceuticals
 HSMN NewsFeed - 10 Jul 2017
Gamida Cell Inc. Names Ronit Simantov, M.D. as Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 5 Jun 2017
Gamida Cell Appoints Nobel Prize Laureate Professor Roger Kornberg and Immune Oncology Expert Dr. Michael Perry to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2017
Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 4 Apr 2017
AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement With Endoceutics for U.S. Rights to Intrarosa(TM) (Prasterone)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Oct 2016
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena(R) and Feraheme(R)
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2015
Cesca Receives Approval for Medicare Coverage
Regenerative Medicine Reimbursement
 HSMN NewsFeed - 26 Oct 2015
Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics
Regenerative Medicine Personnel
 HSMN NewsFeed - 12 Jun 2015
Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Mar 2014
Cesca Therapeutics Submits pre-IDE Information Package to FDA for Surgwerks(TM) CLI therapy System
Regenerative Medicine FDA
 HSMN NewsFeed - 18 Dec 2013
America Stem Cell, Inc. Changes Its Name to Targazyme, Inc.
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 22 Jul 2013
SynGen Hires Former Pall Medical Executive as President of Cord Blood Business Unit
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Feb 2013
Cellerant Appoints William Reed, M.D., as Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 2 Jun 2011
ThermoGenesis Announces 510(k) Approval for Use of Res-Q in Preparation of Platelet Rich Plasma
Devices FDA
 HSMN NewsFeed - 7 Feb 2011
FDA Approves Labeling Update for REYATAZ(R) (atazanavir sulfate) Capsules to Include Data Supporting the Recommended Adult Dose of REYATAZ/ritonavir 300/100 mg for HIV-1 Infected Pregnant Women
Biopharmaceuticals HIV/AIDS FDA
 HSMN NewsFeed - 7 Feb 2011
Cellerant Therapeutics Announces Key Additions to Sr. Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
Aegerion Pharmaceuticals Appoints Marc Beer as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2010
Abbott Receives FDA Approval for First Fully Automated Blood Test for 'Kissing Bug' Disease
Diagnostics FDA
 HSMN NewsFeed - 6 May 2010
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
Devices Surgery Regenerative Medicine Personnel
 HSMN NewsFeed - 26 Apr 2010
ThermoGenesis Extends Global Reach for Bone Marrow Products With New Distribution Agreements
Devices Regenerative Medicine Distribution
 HSMN NewsFeed - 23 Feb 2010
Aldagen Announces Strategic Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2010
Elbit Imaging Announces Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma
Regenerative Medicine Oncology
 HSMN NewsFeed - 16 Nov 2009
Fate Therapeutics Closes $30 Million Series B Financing
Regenerative Medicine Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Sep 2009
Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine
 HSMN NewsFeed - 21 Sep 2009
Abbott Receives FDA Approval for First Fully Automated Blood Screening Test for HIV-1/HIV-2
Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 10 Sep 2009
Stem Cell Therapy International Inc. Announces Histostem Litigation Settlement
Regenerative Medicine Litigation Mergers & Acquisitions
 HSMN NewsFeed - 10 Sep 2009
Pluristem Begins Enrollment in U.S. With Unmatched Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease
Regenerative Medicine
 HSMN NewsFeed - 8 Sep 2009
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Biopharmaceuticals
 HSMN NewsFeed - 16 Jul 2009
Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2009
GTC Biotherapeutics in-Licenses Recombinant Human Alpha-Fetoprotein from Merrimack Pharmaceuticals
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Regenerative Medicine
 HSMN NewsFeed - 8 May 2009
New Data Shows Blood Pressure Reduction Therapy With BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2009
BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 17 Sep 2008
DOR BioPharma Forms orBec(R) European Medical Advisory Board
Biopharmaceuticals
 HSMN NewsFeed - 9 Sep 2008
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
Devices Regenerative Medicine Distribution
 HSMN NewsFeed - 4 Aug 2008
Pluristem Appoints Ms. Chaya Mazouz Clinical Operations Director
Regenerative Medicine Personnel
 HSMN NewsFeed - 23 Jun 2008
EyeCyte, Inc. Secures Series A Funding from Pfizer
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 19 Jun 2008
ThermoGenesis Announces Receipt of CE Mark for MarrowXpress (TM)
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 16 Jun 2008
New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
New Data Shows 45 Percent of Patients With Stage 1 Hypertension Reached Normotension With BENICAR(R) and BENICAR HCT(R)
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2008
Stem Cell Therapy International Amends Merger With Histostem
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 23 Apr 2008
Aldagen Secures $18.4 Million in Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 14 Apr 2008
Stem Cells From Menstrual Blood Show Therapeutic Potential
Regenerative Medicine
 HSMN NewsFeed - 1 Apr 2008
Stem Cell Therapy International Appoints Dr. David L. Stark as President in Anticipation of the Upcoming Merger With Histostem, Ltd. of Korea
Regenerative Medicine Personnel
 HSMN NewsFeed - 20 Mar 2008
Stem Cell Technology Offers Promise of Huge Savings for Drug Developers
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 4 Mar 2008
Pluristem Submits Pre-IND Application in Germany to Initiate Clinical Trials of PLX-PAD for Peripheral Artery Disease
Regenerative Medicine Regulatory
 HSMN NewsFeed - 27 Feb 2008
Stem Cell Therapy International Signs Memorandum of Intent to Merge With a Leading Umbilical Cord Stem Cell Company Histostem, Co., Ltd. of Korea
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 22 Feb 2008
ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets
Devices Product Recall
 HSMN NewsFeed - 18 Jan 2008
Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
Diagnostics FDA
 HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Regenerative Medicine
 HSMN NewsFeed - 15 Nov 2007
PerkinElmer Completes Acquisition of ViaCell
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 6 Nov 2007
First Patient Undergoes Expanded Cord Blood Transplant in the ExCell Registration Study of StemEx(R) for Leukemia and Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Oct 2007
PerkinElmer Commences Cash Tender Offer for ViaCell
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 9 Oct 2007
ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 9 Oct 2007
orBec(R) Clinical Summary Published in "Expert Opinion on Investigational Drugs"
Biopharmaceuticals
 HSMN NewsFeed - 1 Oct 2007
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell
Regenerative Medicine Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 17 Sep 2007
BioLife Solutions' CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
Regenerative Medicine
 HSMN NewsFeed - 13 Sep 2007
Aldagen Raises Additional $9 Million, Increasing Series C Financing to $23 Million
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 22 Aug 2007
ViaCell Expands Study Sites in ViaCyte Pivotal Trial
Regenerative Medicine
 HSMN NewsFeed - 2 Aug 2007
Stem Cell Therapy International Acquires Exclusive Worldwide Rights to New, Anti-Rejection Stem Cell Technology
Regenerative Medicine
 HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Obtains FDA Clearance to Market CryoSeal(R) Fibrin Sealant (FS) in Liver Resection Surgeries
Devices FDA Surgery
 HSMN NewsFeed - 30 Jul 2007
ThermoGenesis Corp. Appoints William Osgood Chief Executive Officer and Director
Devices Personnel
 HSMN NewsFeed - 12 Jul 2007
Abbott Announces Approval of First Fully-Automated Blood Screening Test for Hepatitis C Antibodies
Diagnostics FDA
 HSMN NewsFeed - 11 Jul 2007
StemCyte Appoints Robert Dickey IV as Senior Vice President and Chief Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 21 Jun 2007
Tissue Regeneration Therapeutics Inc. Announces $20 M Stem Cell License to Stem Cell Authority Ltd. for US Market
Regenerative Medicine Licensing
 HSMN NewsFeed - 4 Jun 2007
Generic Medical Devices Announces U.S. Sales Force as First Generic Devices Go to Market
Devices Personnel
 HSMN NewsFeed - 21 May 2007
BENICAR HCT(R) Reductions in Seated Systolic Blood Pressure for Stage 2 Patients Compared With Amlodipine + Benazepril
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 9 May 2007
FDA Advisory Panel Reviews DOR BioPharma's orBec(R) for Treatment of GI GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Apr 2007
ThermoGenesis Announces Record Revenues and Key Executive Changes
Devices Personnel
 HSMN NewsFeed - 21 Mar 2007
Bio Stem, Inc. to Obtain One of the Largest Stem Cell Inventories in the World Through Merger
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 20 Mar 2007
DOR BioPharma Forms orBec(R) Medical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2007
ViaCell Announces Commencement of ViaCyte Pivotal Trial
Regenerative Medicine
 HSMN NewsFeed - 15 Feb 2007
ThermoGenesis Corp. Names Cell Therapy Device Sales Expert Daniel A. Segal as Vice President of Sales & Marketing
Devices Personnel
 HSMN NewsFeed - 14 Feb 2007
Pluristem Announces Private Equity Investment of $8M
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 31 Jan 2007
FDA Advisory Committee to Review DOR BioPharma's orBec(R) for the Treatment of GI GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 22 Jan 2007
ViaCell Appoints Kirk Williamson as Vice President of Marketing
Regenerative Medicine Personnel
 HSMN NewsFeed - 10 Jan 2007
GenesisBPS Announces the North American Distribution and FDA 510K Clearance of the SEPAX Cell Separation System for Cord Blood Processing
Devices FDA
 HSMN NewsFeed - 3 Jan 2007
ThermoGenesis Corp. Appoints Industry Veteran William Osgood as General Manager of Operations
Devices Personnel
 HSMN NewsFeed - 19 Dec 2006
Aldagen Secures $17.3 Million in Financing
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 15 Dec 2006
Aldagen Announces Texas Heart Institute as First Site in its Stem Cell Clinical Trial to Treat Critical Limb Ischemia
Regenerative Medicine
 HSMN NewsFeed - 28 Nov 2006
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 21 Nov 2006
FDA Accepts DOR BioPharma's NDA Filing for orBec(R)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 7 Nov 2006
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 6 Nov 2006
Elbit Medical Group Announces Receipt of a Special Protocol Assessment From the FDA to Gamida Cell's Stemex(R) Registration Study
Regenerative Medicine FDA
 HSMN NewsFeed - 2 Nov 2006
Gamida Cell's StemEx(R) Registration Study Receives Special Protocol Assessment from the FDA
Regenerative Medicine FDA
 HSMN NewsFeed - 31 Oct 2006
Pluristem Expects to Submit Pre-IND Document to FDA by End of 2006
Regenerative Medicine
 HSMN NewsFeed - 26 Oct 2006
NeoStem, Inc. Appoints Julio C. Guerra, MD, ABP, as Director of Sales and Marketing
Regenerative Medicine Personnel
 HSMN NewsFeed - 16 Oct 2006
St. Jude Medical Appoints Dr. Mark D. Carlson as Chief Medical Officer and Senior Vice President, Clinical Affairs, for CRM Division
Devices Cardiology Personnel
 HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Aug 2006
ThermoGenesis Corp. Signs Agreement With Biomet Biologics, Inc. to Produce Intra-Operative Autologous Fibrin Sealant
Devices Surgery Licensing
 HSMN NewsFeed - 20 Jul 2006
Stem Cell Authority Ltd.(TM) Offers Ethical Alternative to Alleviate Political Stem Cell Deadlock Between U.S. Congress and President
Regenerative Medicine
 HSMN NewsFeed - 28 Jun 2006
Different Stem Cell Treatments Both Produce Results for Two Similar Patients in China
Regenerative Medicine Neurology
 HSMN NewsFeed - 14 Jun 2006
ThermoGenesis Expands European Distribution of CryoSeal(R) Fibrin Sealant (FS) System and Thrombin Processing Device(TM) (TPD) to Czech Republic, Slovakia and Greece
Devices Surgery Distribution
 HSMN NewsFeed - 13 Jun 2006
ViaCell Announces Cardiac Collaboration with Centocor Research and Development, Inc.
Regenerative Medicine Cardiology
 HSMN NewsFeed - 31 May 2006
ThermoGenesis & NETCORD Note U.S. Patent Office's Rejection of PharmaStem Cord Blood Stem Cell Patent Claims
Devices Regenerative Medicine Litigation
 HSMN NewsFeed - 30 May 2006
ViaCell Announces New Office Actions Rejecting PharmaStem Patent Claims
Regenerative Medicine Litigation
 HSMN NewsFeed - 19 May 2006
Cleveland Stem-Cell Therapy Start-Up
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 8 May 2006
New Performance Data Presented at ISCT Demonstrates ThermoGenesis' AutoXpress(TM) System (AXP) Efficiently Separates Stem Cells From Cord Blood
Devices Regenerative Medicine
 HSMN NewsFeed - 8 May 2006
BioE Stem Cell First Human Cord Blood Stem Cell to Turn into Lung Cell
Regenerative Medicine
 HSMN NewsFeed - 1 May 2006
U.S. Patent Office Issues Office Actions Rejecting All Claims in Two PharmaStem Umbilical Cord Blood Patents
Regenerative Medicine
 HSMN NewsFeed - 25 Apr 2006
First FDA Clearance of Sterile Field Cord Blood Collection Bag
Devices Regenerative Medicine FDA
 HSMN NewsFeed - 19 Apr 2006
ThermoGenesis Expands CryoSeal(R) Fibrin Sealant System and Thrombin Processing Device(TM) (TPD) Distribution in Europe to United Kingdom and Hungary
Devices Surgery Distribution
 HSMN NewsFeed - 10 Apr 2006
ViaCell Announces Executive Appointments in its Reproductive Health Business
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 3 Apr 2006
Dr. John Chapman Named Vice President of Scientific Affairs
Devices Personnel
 HSMN NewsFeed - 28 Mar 2006
National Stem Cell, Inc. Intends to Merge with Azurel, Ltd.
Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 15 Mar 2006
ThermoGenesis' AXP AutoXpress(TM) Platform is Launched by GE Healthcare as the First Automated Functionally Closed Sterile System for the Processing of Cord Blood Stem Cells
Devices Regenerative Medicine
 HSMN NewsFeed - 6 Mar 2006
Pluristem Strengthens Business Strategy, Company to Focus on Commercializing Cell Therapy Products
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 3 Mar 2006
Group Successfully Improves Life of Youngest-Ever Stroke Patient to be Treated with Umbilical Cord Stem Cells
Regenerative Medicine Neurology
 HSMN NewsFeed - 14 Feb 2006
ThermoGenesis Receives Health Canada Regulatory License to Market the AutoXpress System (AXP(TM))
Devices Regulatory
Return to NewsFeed  

 Additional items found! 64

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 64 additional stories matching:
cord blood
(Password required)
FindReps 2 - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps 2 - available on the Apple App Store for iPhone and iPad.